Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intellectual property policies in early-phase research in public-private partnerships.

× No keyword cloud information.

6 in total

Review 1. Recalibrating intellectual property rights to enhance translational research collaborations.

Authors: Tania Bubela; Garret A FitzGerald; E Richard Gold
Journal: Sci Transl Med Date: 2012-02-22 Impact factor: 17.956

2. Precompetitive research: a new prescription for drug development?

Authors: J Woodcock
Journal: Clin Pharmacol Ther Date: 2010-05 Impact factor: 6.875

3. Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs).

Authors: Hilde Stevens; Geertrui Van Overwalle; Bart Van Looy; Isabelle Huys
Journal: Biotechnol Law Rep Date: 2015-08-01 Impact factor: 0.146

Review 4. The introduction of new vaccines into developing countries. IV: Global Access Strategies.

Authors: Richard T Mahoney; Anatole Krattiger; John D Clemens; Roy Curtiss
Journal: Vaccine Date: 2007-03-07 Impact factor: 3.641

5. Precompetitive activity to address the biological data needs of drug discovery.

Authors: Ben Sidders; Christoph Brockel; Alex Gutteridge; Lee Harland; Peter Gildsig Jansen; Robert McEwen; David Michalovich; Henrik Seidel; Bertram Weiss; Bryn Williams-Jones; Mathew Woodwark
Journal: Nat Rev Drug Discov Date: 2014-02 Impact factor: 84.694

6. Patent-free pact pushes the boundaries of precompetitive research.

Authors: Elie Dolgin
Journal: Nat Med Date: 2014-06 Impact factor: 53.440

6 in total

3 in total

Intellectual property policies in early-phase research in public-private partnerships.

Review 1. Recalibrating intellectual property rights to enhance translational research collaborations.

2. Precompetitive research: a new prescription for drug development?

3. Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs).

Review 4. The introduction of new vaccines into developing countries. IV: Global Access Strategies.

5. Precompetitive activity to address the biological data needs of drug discovery.

6. Patent-free pact pushes the boundaries of precompetitive research.

1. Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology.

Review 2. Innovative Approaches to Increase Access to Medicines in Developing Countries.

Review 3. Virus-like particle vaccines: immunology and formulation for clinical translation.